Current Edition

Pricing pharmaceuticals in Japan
Volume 11 Issue 3

Pricing Pharmaceuticals in Japan

In Japan, all citizens are covered under public health insurance. This universal insurance system is called the National Health Insurance, or NHI, System. It is …

Continue Reading →
Mergers and acquisitions_opportunities
Volume 11 Issue 3

Mergers and Acquisitions: Opportunities and Drivers for CDMOs

Over the past decade, the pharmaceutical industry has shifted remarkably due to the changing needs of customers impacting demand for pharmaceutical products on a global …

Continue Reading →
Monitoring medical devices_the broad implications
Volume 11 Issue 3

Monitoring Medical Devices: The Broad Implications of the Great Regulatory Shake-up

The forthcoming step changes in medical device transparency and traceability requirements, under new European regulations, don’t just affect manufacturers. Ben Jacoby of Sensus Group explains …

Continue Reading →
Global serialisation_Russian track-and-trace
Volume 11 Issue 3

Global Serialisation: Russian Track-and-trace Readiness

On 1 January 2020, Russia will introduce a new, compulsory system for tracking pharmaceuticals from manufacturer to end user. This new legislation should be considered …

Continue Reading →
Pharmacodynamic models as outcome variables
Volume 11 Issue 3

Pharmacodynamic Models as Outcome Variables in Early Respiratory Drug Development

Respiratory drug development is challenging and only 3 per cent of the drugs for which a clinical trial is started end up on the market, …

Continue Reading →
nanomilling_shaping the solubility and...
Volume 11 Issue 3

Nanomilling: Shaping the Solubility and Bioavailability of Today’s Therapeutics

Poor water solubility is an increasingly common issue in pharmaceutical development. Approximately 40% of marketed drugs and as many as 90% of active pharmaceutical ingredients …

Continue Reading →
The unique challenges and opportunities of
Volume 11 Issue 3

The Unique Challenges and Opportunities of Forecasting for Orphan Diseases

The term rare, or orphan disease can encompass any one of more than 6000 conditions. Some, such as cystic fibrosis or Tourette’s syndrome, are well …

Continue Reading →
Formulation of drug product for paediatric
Volume 11 Issue 3

Formulation of Drug Product for Paediatric Population – Challenges

One of the main specificities of the paediatric population is that this is a heterogeneous population. Potential paediatric patients are neonates, newborns, infants and toddlers, …

Continue Reading →
Fighting the zombies_imagine if your body
Volume 11 Issue 3

Fighting the Zombies: Imagine if Your Body Kept Functioning No Matter Your Age!

Senescent cells were first described in the late 1950s but remained largely a curiosity until 2008 when their dark nature was revealed by Dr Judith …

Continue Reading →
Is your temperature data at the clinical site
Volume 11 Issue 3

Is Your Temperature Data at the Clinical Site out of Sight?

We have all heard that the journey is as critical as the destination. However, in the world of clinical supplies, did you know that most …

Continue Reading →